Bellerophon Therapeutics, Inc. 4
4 · Bellerophon Therapeutics, Inc. · Filed Feb 19, 2015
Insider Transaction Report
Form 4
MEGLASSON MARTIN
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2015-02-13+1,995→ 1,995 totalExercise: $12.00Exp: 2025-02-12→ Common Stock (1,995 underlying)
Footnotes (1)
- [F1]This option was granted on February 13, 2015. This option vests as to 25% of the underlying shares on each one year anniversary of the date of grant.